How can clinicians address medication adherence in schizophrenia?

• A. Rely solely on verbal reminders without any family involvement or supports.
• B. Increase the number of daily doses to improve engagement.
• C. Discontinue all psychosocial supports to focus only on medication.
• D. Use long-acting injectable antipsychotics when appropriate, provide psychoeducation, simplify dosing, employ reminder strategies, and involve family or support persons.

Answer: (D)

Addressing medication adherence in schizophrenia involves combining pharmacologic options with practical supports to help patients stay on treatment. Using long-acting injectable antipsychotics when appropriate can maintain steady medication levels without requiring daily dosing, which helps patients who have memory issues, chaotic routines, or difficulty sticking to a daily pill plan. This approach often reduces relapse and hospitalization risk compared with daily oral medications, but it must be considered alongside patient preference, medical suitability, and careful monitoring of side effects. Providing psychoeducation helps patients and their families understand the illness, the purpose of the medication, potential side effects, and what to expect, which boosts motivation and engagement with treatment. Simplifying dosing—favoring once-daily or less frequent regimens when possible—reduces complexity and barriers to adherence. Reminder strategies, such as alarms, digital reminders, or pill organizers, address forgetfulness and create consistent routines around taking medication. Involving family members or other support persons creates a supportive network that can monitor adherence, assist with logistics, and encourage attendance at appointments. Together, these elements form a comprehensive, patient-centered plan. Relying solely on verbal reminders, increasing daily doses without addressing broader barriers, or discarding psychosocial supports misses the multifaceted nature of adherence and is less effective overall.